Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Respiratory Aspiration 1Lymphoma, Follicular 1COVID-19 1

Interventions

Propofol 3Inhalation 3Sevoflurane 2Injections 2Exercise Therapy 2Therapeutics 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sensitivity Training Groups 1Respiration 1Radiotherapy 1Radiosurgery 1Population Groups 1One-Lung Ventilation 1Oils, Volatile 1Midazolam 1Methods 1IBIO123 1Hydrogen 1High-Frequency Jet Ventilation 1Health Records, Personal 1Fentanyl 1Diclofenac 1Cryosurgery 1Control Groups 1Aromatherapy 1Anterior Temporal Lobectomy 1Anesthesia, General 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Respiratory Aspiration × IBIO123 × Clear all
NCT05303376 2023-09-13

Phase 1&2 Study to Evaluate the Safety & Efficacy of Inhaled IBIO123 in Severe COVID-19 Illness

Immune Biosolutions Inc

Phase 1/2 Completed
123 enrolled
Lymphoid

COVID-19, Lymphoma, Follicular, Respiratory Aspiration

Data powered by HemOnc (CC BY 4.0) Colophon âš¡